Clorox CLX
Clorox Q3 FY25: revenue $1.7B, down 8%; diluted EPS $1.50
- Form
- 10-Q
- Filed
- Period
- Importance
- Notable
- Accession
- 0000021076-25-000023
Key figures from this report
These are the numbers Clorox reported for Q3 FY25, the quarter ended Mar 31, 2025, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.
- Revenue$1.7B−8% from $1.8B in Q3 FY2410-Q income statement, on EDGAR
- Net income$186.0MAgainst −$51.0M in Q3 FY2410-Q income statement, on EDGAR
- Diluted EPS$1.50Against −$0.41 in Q3 FY2410-Q income statement, on EDGAR
- Cash and cash equivalents$226.0M+3% from $219.0M in Q3 FY2410-Q balance sheet, on EDGAR
- Cash from operations$286.0M+57% from $182.0M in Q3 FY2410-Q cash flow statement, on EDGAR; the filing reports year-to-date cash flows; this quarter is the year-to-date total less the earlier quarters
Similar companies
Companies of similar size in SIC 2842 and related industry codes: the same peer list as the financial tables.
- Church & Dwight CHD public float $22.9B, Jun 30, 2025
- Estee Lauder Companies EL public float $26.0B, Dec 31, 2025
- Kenvue KVUE public float $39.6B, Jun 27, 2025
- Ecolab ECL public float $67.1B, Jun 30, 2025
- Colgate Palmolive CL public float $73.4B, Jun 30, 2025